Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, Windlas Biotech has informed that it enclosed the Certificate received from Link Intime India, its Registrar and Share Transfer Agent for the Quarter ended September 30, 2022.
The above information is a part of company’s filings submitted to BSE.